[图书][B] Biofilm eradication and prevention: a pharmaceutical approach to medical device infections
T Shunmugaperumal - 2010 - books.google.com
Biofilm Eradication and Preventions presents the basics of biofilm formation on medical
devices, diseases related to this formation, and approaches pharmaceutical researchers …
devices, diseases related to this formation, and approaches pharmaceutical researchers …
Vascular access in therapeutic apheresis: update 2013
L Golestaneh, MH Mokrzycki - Journal of clinical apheresis, 2013 - Wiley Online Library
This review addresses the types of vascular access available for patients who need
therapeutic apheresis (TA). As in hemodialysis, vascular access for TA is chosen based on …
therapeutic apheresis (TA). As in hemodialysis, vascular access for TA is chosen based on …
Interventional nephrology: catheter dysfunction—prevention and troubleshooting
VD Niyyar, MR Chan - Clinical Journal of the American Society of …, 2013 - journals.lww.com
Despite recommendations by various national guidelines advocating arteriovenous fistulae
as the access of choice in patients undergoing hemodialysis (HD), the use of central venous …
as the access of choice in patients undergoing hemodialysis (HD), the use of central venous …
[HTML][HTML] Cefazolin–gentamicin versus taurolidine–citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: a quasi-experimental trial
TNV Bueloni, D Marchi, C Caetano… - International Journal of …, 2019 - Elsevier
Background Catheter-related bloodstream infection (CR-BSI) is one of various complications
related to hemodialysis (HD). As a result of the high rate of infection, the use of lock solutions …
related to hemodialysis (HD). As a result of the high rate of infection, the use of lock solutions …
Long-term follow-up of the Hemodialysis Infection Prevention with Polysporin Ointment (HIPPO) Study: a quality improvement report
M Battistella, C Bhola, CE Lok - American journal of kidney diseases, 2011 - Elsevier
BACKGROUND:: Infection is a common and serious complication in hemodialysis patients
accessed using central venous catheters (CVCs). Previously, a randomized double-blinded …
accessed using central venous catheters (CVCs). Previously, a randomized double-blinded …
Trisodium citrate 4% versus heparin as a catheter lock for non-tunneled hemodialysis catheters in critically ill patients: a multicenter, randomized clinical trial
JP Quenot, J Helms, A Bourredjem, A Dargent… - Annals of intensive …, 2019 - Springer
Background Non-tunneled hemodialysis catheters are currently used for critically ill patients
with acute kidney injury requiring extracorporeal renal replacement therapy. Strategies to …
with acute kidney injury requiring extracorporeal renal replacement therapy. Strategies to …
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end‐stage kidney disease
Y Wang, JN Ivany, V Perkovic… - Cochrane Database …, 2016 - cochranelibrary.com
Background Catheter malfunction, including thrombosis, is associated with reduced dialysis
adequacy, as well as an increased risk of catheter‐related bacteraemia and mortality. The …
adequacy, as well as an increased risk of catheter‐related bacteraemia and mortality. The …
Nitric Oxide-Releasing Hemodialysis Catheter Lock Solutions
SE Maloney, QE Grayton, C Wai… - … Applied Materials & …, 2023 - ACS Publications
In an attempt to address the significant morbidity, mortality, and economic cost associated
with tunneled dialysis catheter (TDC) dysfunction, we report the development of nitric oxide …
with tunneled dialysis catheter (TDC) dysfunction, we report the development of nitric oxide …
Exit of catheter lock solutions from double lumen acute haemodialysis catheters—an in vitro study
M Sungur, E Eryuksel, S Yavas… - Nephrology Dialysis …, 2007 - academic.oup.com
Background. Double lumen dialysis catheters are routinely heparin or citrate 'locked'to
maintain patency. Heparin lock-related bleeding episodes and antibiotic lock-related toxicity …
maintain patency. Heparin lock-related bleeding episodes and antibiotic lock-related toxicity …
Observational Study of need for thrombolytic therapy and incidence of bacteremia using taurolidine‐citrate‐heparin, taurolidine‐citrate and heparin catheter locks in …
LR Solomon, JS Cheesbrough, R Bhargava… - Seminars in …, 2012 - Wiley Online Library
Catheter‐related blood stream infections may be reduced by interdialytic locking with
Taurolidine, a nontoxic antimicrobial agent. A formulation of 1.35% Taurolidine in 4% citrate …
Taurolidine, a nontoxic antimicrobial agent. A formulation of 1.35% Taurolidine in 4% citrate …